ACXP Earnings Acurx Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.62 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -5.32 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -5.01 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -4.01 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.15 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -17.45 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -14.23 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -10.84 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.28 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -1.15 | 2025-03-17 | 10-K |
| Q3 2024 | 2023-09-30 | -0.77 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.53 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.25 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -1.12 | 2024-03-15 | 10-K |
| Q3 2023 | 2022-09-30 | -0.84 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.52 | 2023-08-11 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.26 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -1.49 | 2023-03-15 | 10-K |
| Q3 2022 | 2021-09-30 | -1.27 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.79 | 2022-08-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.